| RS2102817952 |
LMNA
|
Health Risk |
Likely pathogenic |
7 conditions, 7 conditions |
| RS2102818068 |
LMNA
|
Health Risk |
Pathogenic |
Charcot-Marie-Tooth disease type 2, Charcot-Marie-Tooth disease type 2 |
| RS2102818172 |
LMNA
|
Health Risk |
Likely pathogenic |
Charcot-Marie-Tooth disease type 2, Charcot-Marie-Tooth disease type 2 |
| RS2102818240 |
LMNA
|
Health Risk |
Pathogenic |
Charcot-Marie-Tooth disease type 2, Charcot-Marie-Tooth disease type 2 |
| RS2102818589 |
PAPPA2
|
Health Risk |
Pathogenic |
Short stature, Dauber-Argente type |
| RS2102818731 |
LMNA
|
Health Risk |
Pathogenic |
Charcot-Marie-Tooth disease type 2, Charcot-Marie-Tooth disease type 2 |
| RS2102818745 |
LMNA
|
Health Risk |
Pathogenic |
Charcot-Marie-Tooth disease type 2, Charcot-Marie-Tooth disease type 2 |
| RS2102818749 |
LMNA
|
Health Risk |
Pathogenic |
Charcot-Marie-Tooth disease type 2, Charcot-Marie-Tooth disease type 2 |
| RS2102818914 |
LMNA
|
Health Risk |
Likely pathogenic |
— |
| RS2102821722 |
USH2A
|
Health Risk |
Pathogenic |
— |
| RS2102821808 |
USH2A
|
Health Risk |
Pathogenic |
— |
| RS2102823161 |
USH2A
|
Health Risk |
Pathogenic |
— |
| RS2102823179 |
USH2A
|
Health Risk |
Pathogenic |
— |
| RS2102823316 |
USH2A
|
Health Risk |
Pathogenic |
— |
| RS2102823350 |
USH2A
|
Health Risk |
Pathogenic |
— |
| RS2102823618 |
GNPAT
|
Health Risk |
Likely pathogenic |
— |
| RS2102824382 |
RYR2
|
Health Risk |
Conflicting classifications of pathogenicity |
Catecholaminergic polymorphic ventricular tachycardia 1, Catecholaminergic polymorphic ventricular tachycardia 1 |
| RS2102825068 |
GNPAT
|
Health Risk |
Pathogenic |
Rhizomelic chondrodysplasia punctata, Rhizomelic chondrodysplasia punctata |
| RS2102825771 |
TMEM63A
|
Health Risk |
Pathogenic |
Leukodystrophy, hypomyelinating |
| RS2102832737 |
IARS2
|
Health Risk |
Likely pathogenic |
— |
| RS2102837157 |
IARS2
|
Health Risk |
Pathogenic |
— |
| RS2102839341 |
IARS2
|
Health Risk |
Pathogenic |
— |
| RS2102844404 |
B3GALNT2
|
Health Risk |
Likely pathogenic |
Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type a |
| RS2102857548 |
TBCE
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Inborn genetic diseases |
| RS2102859415 |
RAB3GAP2
|
Health Risk |
Pathogenic |
Martsolf syndrome 1, Martsolf syndrome 1 |
| RS2102863392 |
B3GALNT2
|
Health Risk |
Likely pathogenic |
Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type a |
| RS2102864339 |
LYST
|
Health Risk |
Likely pathogenic |
Autoinflammatory syndrome, Autoinflammatory syndrome |
| RS2102865393 |
LMNA
|
Health Risk |
Conflicting classifications of pathogenicity |
Cardiomyopathy, Dilated cardiomyopathy 1A |
| RS2102865805 |
LMNA
|
Health Risk |
Pathogenic |
Charcot-Marie-Tooth disease type 2, Charcot-Marie-Tooth disease type 2 |
| RS2102866054 |
RAB3GAP2
|
Health Risk |
Pathogenic |
Martsolf syndrome, Warburg micro syndrome 2 |
| RS2102866080 |
RAB3GAP2
|
Health Risk |
Likely pathogenic |
— |
| RS2102866096 |
RAB3GAP2
|
Health Risk |
Pathogenic |
Martsolf syndrome 1, Martsolf syndrome 1 |
| RS2102875639 |
NCF2
|
Health Risk |
Likely pathogenic |
Chronic granulomatous disease, Chronic granulomatous disease |
| RS2102878324 |
LMNA
|
Health Risk |
Pathogenic |
Charcot-Marie-Tooth disease type 2, Charcot-Marie-Tooth disease type 2 |
| RS2102878838 |
NTRK1
|
Health Risk |
Likely pathogenic |
Hereditary insensitivity to pain with anhidrosis, Hereditary insensitivity to pain with anhidrosis |
| RS2102878843 |
NTRK1
|
Health Risk |
Likely pathogenic |
Hereditary insensitivity to pain with anhidrosis, Hereditary insensitivity to pain with anhidrosis |
| RS2102878915 |
LMNA
|
Health Risk |
Conflicting classifications of pathogenicity |
Charcot-Marie-Tooth disease type 2, Cardiovascular phenotype |
| RS2102879250 |
LMNA
|
Health Risk |
Pathogenic |
Charcot-Marie-Tooth disease type 2, Charcot-Marie-Tooth disease type 2 |
| RS2102879360 |
LMNA
|
Health Risk |
Pathogenic |
Charcot-Marie-Tooth disease type 2, Cardiovascular phenotype |
| RS2102880436 |
B3GALNT2
|
Health Risk |
Pathogenic |
Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type a |
| RS2102880445 |
RAB3GAP2
|
Health Risk |
Likely pathogenic |
— |
| RS2102881081 |
LMNA
|
Health Risk |
Conflicting classifications of pathogenicity |
Familial partial lipodystrophy, Dunnigan type |
| RS2102881813 |
LMNA
|
Health Risk |
Likely pathogenic |
Abnormality of the musculature, Abnormality of the musculature |
| RS2102882192 |
LMNA
|
Health Risk |
Pathogenic |
Charcot-Marie-Tooth disease type 2, Charcot-Marie-Tooth disease type 2 |
| RS2102883099 |
LMNA
|
Health Risk |
Pathogenic/Likely pathogenic |
Charcot-Marie-Tooth disease type 2, Dilated cardiomyopathy 1A |
| RS2102883169 |
LMNA
|
Health Risk |
Pathogenic/Likely pathogenic |
Charcot-Marie-Tooth disease type 2, 11 conditions |
| RS2102884287 |
LMNA
|
Health Risk |
Conflicting classifications of pathogenicity |
Charcot-Marie-Tooth disease type 2, Charcot-Marie-Tooth disease type 2 |
| RS2102885144 |
NTRK1
|
Health Risk |
Likely pathogenic |
— |
| RS2102885150 |
NTRK1
|
Health Risk |
Likely pathogenic |
Hereditary insensitivity to pain with anhidrosis, Hereditary insensitivity to pain with anhidrosis |
| RS2102885178 |
NTRK1
|
Health Risk |
Pathogenic |
Hereditary insensitivity to pain with anhidrosis, Hereditary insensitivity to pain with anhidrosis |
| RS2102885187 |
NTRK1
|
Health Risk |
Pathogenic |
Hereditary insensitivity to pain with anhidrosis, Hereditary insensitivity to pain with anhidrosis |
| RS2102886126 |
NTRK1
|
Health Risk |
Likely pathogenic |
Neurodevelopmental disorder, Neurodevelopmental disorder |
| RS2102886311 |
NTRK1
|
Health Risk |
Likely pathogenic |
Hereditary insensitivity to pain with anhidrosis, Hereditary insensitivity to pain with anhidrosis |
| RS2102886618 |
LMNA
|
Health Risk |
Conflicting classifications of pathogenicity |
Charcot-Marie-Tooth disease type 2, Charcot-Marie-Tooth disease type 2 |
| RS2102886914 |
LMNA
|
Health Risk |
Conflicting classifications of pathogenicity |
Charcot-Marie-Tooth disease type 2, Charcot-Marie-Tooth disease type 2 |
| RS2102887031 |
LMNA
|
Health Risk |
Pathogenic |
Charcot-Marie-Tooth disease type 2, Charcot-Marie-Tooth disease type 2 |
| RS2102887348 |
NCF2
|
Health Risk |
Likely pathogenic |
Granulomatous disease, chronic |
| RS2102888292 |
LMNA
|
Health Risk |
Pathogenic |
Charcot-Marie-Tooth disease type 2, Cardiovascular phenotype |
| RS2102888695 |
LMNA
|
Health Risk |
Pathogenic |
Charcot-Marie-Tooth disease type 2, Charcot-Marie-Tooth disease type 2 |
| RS2102889960 |
LMNA
|
Health Risk |
Pathogenic |
Charcot-Marie-Tooth disease type 2, Charcot-Marie-Tooth disease type 2 |
| RS2102890051 |
LMNA
|
Health Risk |
Pathogenic |
Charcot-Marie-Tooth disease type 2, Cardiovascular phenotype |
| RS2102890220 |
LMNA
|
Health Risk |
Pathogenic |
Charcot-Marie-Tooth disease type 2, Charcot-Marie-Tooth disease type 2 |
| RS2102890245 |
LMNA
|
Health Risk |
Pathogenic |
Charcot-Marie-Tooth disease type 2, Charcot-Marie-Tooth disease type 2 |
| RS2102890652 |
NCF2
|
Health Risk |
Pathogenic |
Granulomatous disease, chronic |
| RS2102890974 |
LMNA
|
Health Risk |
Pathogenic |
Charcot-Marie-Tooth disease type 2, Cardiovascular phenotype |
| RS2102891243 |
LMNA
|
Health Risk |
Pathogenic/Likely pathogenic |
Charcot-Marie-Tooth disease type 2, Charcot-Marie-Tooth disease type 2 |
| RS2102891563 |
WDR26
|
Health Risk |
Pathogenic |
Skraban-Deardorff syndrome, Skraban-Deardorff syndrome |
| RS2102891579 |
LMNA
|
Health Risk |
Pathogenic |
Charcot-Marie-Tooth disease type 2, Charcot-Marie-Tooth disease type 2 |
| RS2102891660 |
LMNA
|
Health Risk |
Conflicting classifications of pathogenicity |
Primary dilated cardiomyopathy, Primary dilated cardiomyopathy |
| RS2102893113 |
NTRK1
|
Health Risk |
Pathogenic |
Hereditary insensitivity to pain with anhidrosis, Hereditary insensitivity to pain with anhidrosis |
| RS2102893473 |
NTRK1
|
Health Risk |
Likely pathogenic |
Ovarian cancer, Ovarian cancer |
| RS2102893640 |
LMNA
|
Health Risk |
Likely pathogenic |
— |
| RS2102893828 |
LMNA
|
Health Risk |
Pathogenic |
Charcot-Marie-Tooth disease type 2, Charcot-Marie-Tooth disease type 2 |
| RS2102894271 |
NTRK1
|
Health Risk |
Pathogenic |
Hereditary insensitivity to pain with anhidrosis, Hereditary insensitivity to pain with anhidrosis |
| RS2102894535 |
NTRK1
|
Health Risk |
Likely pathogenic |
Hereditary insensitivity to pain with anhidrosis, Hereditary insensitivity to pain with anhidrosis |
| RS2102894883 |
ACTN2
|
Health Risk |
Likely pathogenic |
Dilated cardiomyopathy 1AA, Dilated cardiomyopathy 1AA |
| RS2102895466 |
LMNA
|
Health Risk |
Pathogenic |
Charcot-Marie-Tooth disease type 2, Cardiovascular phenotype |
| RS2102895541 |
LMNA
|
Health Risk |
Pathogenic |
Charcot-Marie-Tooth disease type 2, Charcot-Marie-Tooth disease type 2 |
| RS2102896007 |
LMNA
|
Health Risk |
Pathogenic/Likely pathogenic |
Charcot-Marie-Tooth disease type 2, Charcot-Marie-Tooth disease type 2 |
| RS2102896324 |
LMNA
|
Health Risk |
Likely pathogenic |
Charcot-Marie-Tooth disease type 2, Cardiovascular phenotype |
| RS2102897778 |
WDR26
|
Health Risk |
Likely pathogenic |
Skraban-Deardorff syndrome, Skraban-Deardorff syndrome |
| RS2102897826 |
WDR26
|
Health Risk |
Pathogenic |
Skraban-Deardorff syndrome, Skraban-Deardorff syndrome |
| RS2102898170 |
EGLN1
|
Health Risk |
Pathogenic |
Erythrocytosis, familial |
| RS2102898301 |
LMNA
|
Health Risk |
Likely pathogenic |
Cardiomyopathy, 11 conditions |
| RS2102898304 |
NCF2
|
Health Risk |
Likely pathogenic |
Granulomatous disease, chronic |
| RS2102900184 |
NTRK1
|
Health Risk |
Pathogenic |
Hereditary insensitivity to pain with anhidrosis, Hereditary insensitivity to pain with anhidrosis |
| RS2102900454 |
NTRK1
|
Health Risk |
Likely pathogenic |
Hereditary insensitivity to pain with anhidrosis, Hereditary insensitivity to pain with anhidrosis |
| RS2102901069 |
LMNA
|
Health Risk |
Likely pathogenic |
Familial partial lipodystrophy, Dunnigan type |
| RS2102901580 |
LMNA
|
Health Risk |
Conflicting classifications of pathogenicity |
Charcot-Marie-Tooth disease type 2, 11 conditions |
| RS2102901937 |
LMNA
|
Health Risk |
Likely pathogenic |
Cardiomyopathy, Cardiomyopathy |
| RS2102903043 |
NCF2
|
Health Risk |
Likely pathogenic |
Granulomatous disease, chronic |
| RS2102904669 |
NTRK1
|
Health Risk |
Likely pathogenic |
Hereditary insensitivity to pain with anhidrosis, Hereditary insensitivity to pain with anhidrosis |
| RS2102905325 |
WDR26
|
Health Risk |
Likely pathogenic |
Skraban-Deardorff syndrome, Skraban-Deardorff syndrome |
| RS2102905446 |
NTRK1
|
Health Risk |
Pathogenic |
Hereditary insensitivity to pain with anhidrosis, Hereditary insensitivity to pain with anhidrosis |
| RS2102906069 |
NTRK1
|
Health Risk |
Pathogenic |
Hereditary insensitivity to pain with anhidrosis, Hereditary insensitivity to pain with anhidrosis |
| RS2102908451 |
PRUNE1
|
Health Risk |
Pathogenic |
Neurodevelopmental disorder with microcephaly, hypotonia |
| RS2102910660 |
CACNA1E
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Inborn genetic diseases |
| RS2102912108 |
NTRK1
|
Health Risk |
Pathogenic |
Hereditary insensitivity to pain with anhidrosis, Hereditary insensitivity to pain with anhidrosis |
| RS2102912139 |
NTRK1
|
Health Risk |
Pathogenic |
Hereditary insensitivity to pain with anhidrosis, Hereditary insensitivity to pain with anhidrosis |
| RS2102912811 |
WDR26
|
Health Risk |
Conflicting classifications of pathogenicity |
— |